Kelley Robert J. 4
4 · Talis Biomedical Corp · Filed Oct 5, 2021
Insider Transaction Report
Form 4
Kelley Robert J.
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2021-10-02+130,000→ 427,202 totalExercise: $6.17Exp: 2031-10-01→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.
- [F2]Price not required on initial report of stock option granted.